Atlas Trials

Primary Hyperoxaluria Type 1

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Hyperoxaluria Type 1

RecordFirmDate
Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function (NCT05001269)Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2022-02-22
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) (NCT04982393)Alnylam Pharmaceuticals2021-12-13
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD (NCT04580420)Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2021-04-15
A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 (NCT04152200)Alnylam Pharmaceuticals2020-01-21
Early Check: Expanded Screening in Newborns (NCT03655223)RTI International2018-10-15
Proteomics of Primary Hyperoxaluria Type 1 (NCT03067142)Ann & Robert H Lurie Children's Hospital of Chicago2017-01-05
A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1) (NCT02795325)Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2016-05-13
IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA (NCT02830009)Hospices Civils de Lyon2013-05-01

Track Primary Hyperoxaluria Type 1 automatically

Every clearance here is in the API, with alerts when new ones post.